The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on Focal therapy using high-intensity focused ultrasound for localised prostate cancer.


The prostate is a small gland near a man's bladder. Symptoms of localised prostate cancer include difficulties in passing urine, although the disease is often diagnosed before symptoms develop. Focal therapy using high-intensity focused ultrasound aims to find and destroy only the cancerous parts of the prostate, avoiding treatment of healthy tissue. High-intensity ultrasound is delivered to the tumour areas, which are destroyed through heating. The procedure aims to lower the risk of side effects that can occur when radical treatment is given to the whole of the prostate gland (such as loss of bladder control and sexual function).

Coding recommendations

M71.1 High intensity focused ultrasound of prostate


Y53.2 Approach to organ under ultrasonic control


Y53.7 Approach to organ under magnetic resonance imaging control

In addition the ICD-10 code C61.X Malignant neoplasm of prostate would be recorded.

  • National Institute for Health and Care Excellence (NICE) accreditation logo